Roche(US:RHHBY) Prnewswire·2024-07-25 13:00Core Insights - Roche will showcase its laboratory of the future exhibit at the 2024 ADLM Scientific Meeting and Clinical Lab Expo, highlighting integrated systems and data solutions that optimize resources and improve health outcomes [1][10] Product Innovations - The future cobas® Mass Spec solution aims for seamless integration into routine laboratory operations [2] - The new CCM Vertical system is designed for effective use of lab space and integrates with existing cobas® modules [2] - The cobas® liat system provides rapid PCR results within 20 minutes for multiple respiratory viruses [2] - The cobas® pure integrated solutions combine various diagnostic testing on a single platform for low- to mid-volume needs [2] - The cobas® eplex system has been updated for enhanced workflow efficiency [2] - The cobas® 5800 is a fully automated molecular PCR-testing solution with a comprehensive assay menu [2] - The cobas® LightCycler® PRO is designed for accuracy and flexibility in research and clinical diagnostics [2] Educational Sessions - Roche will present eight Idea Lab segments discussing topics like mass spectrometry, digital solutions, and high-medical-value assays for conditions such as Alzheimer's and heart failure [4][10] - Sessions will cover innovative strategies for enhancing patient access to STI testing and the implementation of heart failure risk monitoring in diabetes patients [5][6] Digital Solutions - Roche's navify® digital solutions integrate data across care settings, enhancing access to innovation and insights [12][13] Company Overview - Founded in 1896, Roche is the world's largest biotechnology company and a leader in in-vitro diagnostics, focusing on scientific excellence to improve healthcare [8][20] - Roche has been recognized as one of the most sustainable companies in the pharmaceuticals industry for fifteen consecutive years [25]